{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:32:39Z","timestamp":1781879559813,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02106-8","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T06:22:08Z","timestamp":1747808528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploration of 1-(2,4-difluorophenyl)-5-oxopyrrolidine-3-carboxylic acid derivatives effect on triple-negative breast, prostate cancer and melanoma cell 2D and 3D cultures"],"prefix":"10.1038","volume":"15","author":[{"given":"Guoda","family":"Pranaityt\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birut\u0117","family":"Grybait\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugne","family":"Endriulaityte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytautas","family":"Mickevi\u010dius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Petrikait\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"2106_CR1","unstructured":"Cancer Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer (accessed on 23 July 2024)."},{"key":"2106_CR2","doi-asserted-by":"publisher","first-page":"7636","DOI":"10.1021\/jm300663n","volume":"55","author":"S Ruf","year":"2012","unstructured":"Ruf, S. et al. Novel \u03b2-Amino acid derivatives as inhibitors of cathepsin A. J. Med. Chem. 55, 7636\u20137649. https:\/\/doi.org\/10.1021\/jm300663n (2012).","journal-title":"J. Med. Chem."},{"key":"2106_CR3","doi-asserted-by":"publisher","unstructured":"Rehman, M., Mahboob Ahmad, F. U. & Naveed Riaz, M. ??-Amino acids: role in human biology and medicinal Chemistry - A review. Med. Chem. 7 https:\/\/doi.org\/10.4172\/2161-0444.1000472 (2017).","DOI":"10.4172\/2161-0444.1000472"},{"key":"2106_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ja.2015.103","volume":"69","author":"S Uesugi","year":"2016","unstructured":"Uesugi, S. et al. Pyrrocidine A, a metabolite of endophytic fungi, has a potent Apoptosis-Inducing activity against HL60 cells through caspase activation via the Michael addition. J. Antibiot. 69, 133\u2013140. https:\/\/doi.org\/10.1038\/ja.2015.103 (2016).","journal-title":"J. Antibiot."},{"key":"2106_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/ph15070791","volume":"15","author":"ML Jeli\u010di\u0107","year":"2022","unstructured":"Jeli\u010di\u0107, M. L., Kova\u010di\u0107, J., Cvetni\u0107, M. & Mornar, A. Amid\u017ei\u0107 klari\u0107, D. Antioxidant activity of pharmaceuticals: predictive QSAR modeling for potential therapeutic strategy. Pharmaceuticals 15, 791. https:\/\/doi.org\/10.3390\/ph15070791 (2022).","journal-title":"Pharmaceuticals"},{"key":"2106_CR6","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3390\/molecules26082389","volume":"26","author":"O Afzal","year":"2021","unstructured":"Afzal, O. et al. Analgesic and anticancer activity of Benzoxazole clubbed 2-Pyrrolidinones as novel inhibitors of monoacylglycerol lipase. Molecules 26, 2389. https:\/\/doi.org\/10.3390\/molecules26082389 (2021).","journal-title":"Molecules"},{"key":"2106_CR7","doi-asserted-by":"publisher","unstructured":"Muneer, S., Memon, S., Pahnwar, Q. K., Bhatti, A. A. & Khokhar, T. S. Synthesis and investigation of antimicrobial properties of pyrrolidine appended Calix[4]Arene. J. Anal. Sci. Technol. 8 (3). https:\/\/doi.org\/10.1186\/s40543-017-0111-3 (2017).","DOI":"10.1186\/s40543-017-0111-3"},{"key":"2106_CR8","doi-asserted-by":"publisher","unstructured":"Khalifa, M. E. et al. Synthesis, antibacterial, and anti HepG2 cell line human hepatocyte carcinoma activity of some new potentially Benzimidazole-5-(Aryldiazenyl)Thiazole derivatives. Molecules 23 (3285). https:\/\/doi.org\/10.3390\/molecules23123285 (2018).","DOI":"10.3390\/molecules23123285"},{"key":"2106_CR9","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/12081910","volume":"12","author":"S Rollas","year":"2007","unstructured":"Rollas, S. & K\u00fc\u00e7\u00fckg\u00fczel, S. G. Biological activities of hydrazone derivatives. Molecules 12, 1910\u20131939. https:\/\/doi.org\/10.3390\/12081910 (2007).","journal-title":"Molecules"},{"key":"2106_CR10","doi-asserted-by":"publisher","unstructured":"I\u015fik, A. et al. Benzimidazole-Hydrazone derivatives: synthesis, in vitro anticancer, antimicrobial, antioxidant activities, in Silico DFT and ADMET studies. J. Mol. Struct. 1270 https:\/\/doi.org\/10.1016\/j.molstruc.2022.133946 (2022).","DOI":"10.1016\/j.molstruc.2022.133946"},{"key":"2106_CR11","doi-asserted-by":"publisher","first-page":"139523","DOI":"10.1016\/j.molstruc.2024.139523","volume":"1319","author":"A Xing","year":"2025","unstructured":"Xing, A. et al. Anticancer and antioxidant activities of novel heterocyclic phenolic hydrazone based derivatives: investigation of DFT calculation, molecular Docking and Drug-Likeness studies. J. Mol. Struct. 1319, 139523. https:\/\/doi.org\/10.1016\/j.molstruc.2024.139523 (2025).","journal-title":"J. Mol. Struct."},{"key":"2106_CR12","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1007\/s11696-023-02804-5","volume":"77","author":"G Chandra","year":"2023","unstructured":"Chandra, G., Singh, D. V., Mahato, G. K. & Patel, S. Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs. Chem. Pap. 77, 4085\u20134106. https:\/\/doi.org\/10.1007\/s11696-023-02804-5 (2023).","journal-title":"Chem. Pap"},{"key":"2106_CR13","doi-asserted-by":"publisher","first-page":"116722","DOI":"10.1016\/j.ejmech.2024.116722","volume":"276","author":"HN Liu","year":"2024","unstructured":"Liu, H. N. et al. Synthetic approaches and application of representative clinically approved Fluorine-Enriched Anti-Cancer medications. Eur. J. Med. Chem. 276, 116722. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116722 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"2106_CR14","doi-asserted-by":"publisher","unstructured":"Afifi, N. & Barrero, C. A. Understanding breast Cancer aggressiveness and its implications in diagnosis and treatment. JCM 12 (1375). https:\/\/doi.org\/10.3390\/jcm12041375 (2023).","DOI":"10.3390\/jcm12041375"},{"key":"2106_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global Cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"2106_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/S0022-5347(17)38540-3","volume":"145","author":"AR Brothman","year":"1991","unstructured":"Brothman, A. R., Wilkins, P. C., Sales, E. W. & Somers, K. D. Metastatic properties of the human prostatic cell line, PPC-1, in athymic nude mice. J. Urol. 145, 1088\u20131091. https:\/\/doi.org\/10.1016\/S0022-5347(17)38540-3 (1991).","journal-title":"J. Urol."},{"key":"2106_CR17","unstructured":"International Agency for Research on Cancer. Cancer Tomorrow Estimated Number of New Cases from 2020 to 2040 of Melanoma of Skin and Non-Melanoma Skin Cancer. Available online: https:\/\/gco.iarc.who.int\/today\/ (accessed on 25 July 2024)."},{"key":"2106_CR18","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.3390\/cancers14194652","volume":"14","author":"J Lopes","year":"2022","unstructured":"Lopes, J., Rodrigues, C. M. P., Gaspar, M. M. & Reis, C. P. Melanoma management: from epidemiology to treatment and latest advances. Cancers 14, 4652. https:\/\/doi.org\/10.3390\/cancers14194652 (2022).","journal-title":"Cancers"},{"key":"2106_CR19","unstructured":"Treating Melanoma Skin Cancer | How Is Melanoma Treated?. Available online: July (2024). https:\/\/www.cancer.org\/cancer\/types\/melanoma-skin-cancer\/treating.html (accessed on 26."},{"key":"2106_CR20","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41416-021-01486-8","volume":"125","author":"S Bouchereau","year":"2021","unstructured":"Bouchereau, S. et al. Impact of prior treatment with immune checkpoint inhibitors on Dacarbazine efficacy in metastatic melanoma. Br. J. Cancer. 125, 948\u2013954. https:\/\/doi.org\/10.1038\/s41416-021-01486-8 (2021).","journal-title":"Br. J. Cancer"},{"key":"2106_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13046-018-0982-1","volume":"37","author":"S Rossi","year":"2018","unstructured":"Rossi, S. et al. TNF-Alpha and metalloproteases as key players in melanoma cells aggressiveness. J. Exp. Clin. Cancer Res. 37, 326. https:\/\/doi.org\/10.1186\/s13046-018-0982-1 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2106_CR22","doi-asserted-by":"publisher","unstructured":"Ghasemi, M., Turnbull, T., Sebastian, S. & Kempson, I. The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and Single-Cell analysis. IJMS 22 (12827). https:\/\/doi.org\/10.3390\/ijms222312827 (2021).","DOI":"10.3390\/ijms222312827"},{"key":"2106_CR23","doi-asserted-by":"publisher","first-page":"103658","DOI":"10.1016\/j.bioorg.2020.103658","volume":"97","author":"B Balandis","year":"2020","unstructured":"Balandis, B. et al. Synthesis and Structure\u2013Affinity relationship of chlorinated Pyrrolidinone-Bearing benzenesulfonamides as human carbonic anhydrase inhibitors. Bioorg. Chem. 97, 103658. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103658 (2020).","journal-title":"Bioorg. Chem."},{"key":"2106_CR24","unstructured":"SUNITINIB. A Comprehensive Guide for Patients Available online: April (2025). https:\/\/clinicaltrials.eu\/inn\/sunitinib\/ (accessed on 22."},{"key":"2106_CR25","first-page":"97","volume":"11","author":"A Brown","year":"2019","unstructured":"Brown, A., Kumar, S. & Tchounwou, P. B. Cisplatin-Based chemotherapy of human cancers. J. Cancer Sci. Ther. 11, 97 (2019).","journal-title":"J. Cancer Sci. Ther."},{"key":"2106_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/cells12040659","volume":"12","author":"M Kciuk","year":"2023","unstructured":"Kciuk, M. et al. Doxorubicin\u2014An agent with multiple mechanisms of anticancer activity. Cells 12, 659. https:\/\/doi.org\/10.3390\/cells12040659 (2023).","journal-title":"Cells"},{"key":"2106_CR27","doi-asserted-by":"publisher","first-page":"28200","DOI":"10.1074\/jbc.M110.216382","volume":"286","author":"C Bedia","year":"2011","unstructured":"Bedia, C., Casas, J., Andrieu-Abadie, N., Fabri\u00e0s, G. & Levade, T. Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to Dacarbazine. J. Biol. Chem. 286, 28200\u201328209. https:\/\/doi.org\/10.1074\/jbc.M110.216382 (2011).","journal-title":"J. Biol. Chem."},{"key":"2106_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/md22070315","volume":"22","author":"WM Piskorz","year":"2024","unstructured":"Piskorz, W. M., Kr\u0119towski, R., Cechowska-Pasko, M. & Marizomib Salinosporamide A) promotes apoptosis in A375 and G361 melanoma Cancer cells. Mar. Drugs. 22, 315. https:\/\/doi.org\/10.3390\/md22070315 (2024).","journal-title":"Mar. Drugs"},{"key":"2106_CR29","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3892\/or.2017.5963","volume":"38","author":"FG Cordaro","year":"2017","unstructured":"Cordaro, F. G. et al. Phenotype characterization of human melanoma cells resistant to Dabrafenib. Oncol. Rep. 38, 2741\u20132751. https:\/\/doi.org\/10.3892\/or.2017.5963 (2017).","journal-title":"Oncol. Rep."},{"key":"2106_CR30","doi-asserted-by":"publisher","first-page":"117009","DOI":"10.1016\/j.lfs.2019.117009","volume":"239","author":"I Janu\u0161kevi\u010dien\u0117","year":"2019","unstructured":"Janu\u0161kevi\u010dien\u0117, I. & Petrikait\u0117, V. Heterogeneity of breast cancer: the importance of interaction between different tumor cell populations. Life Sci. 239, 117009. https:\/\/doi.org\/10.1016\/j.lfs.2019.117009 (2019).","journal-title":"Life Sci."},{"key":"2106_CR31","first-page":"3368","volume":"13","author":"I Janu\u0161kevi\u010dien\u0117","year":"2023","unstructured":"Janu\u0161kevi\u010dien\u0117, I. & Petrikait\u0117, V. Interaction of phenotypic sublines isolated from Triple-Negative breast Cancer cell line MDA-MB-231 modulates their sensitivity to Paclitaxel and doxorubicin in 2D and 3D assays. Am. J. Cancer Res. 13, 3368\u20133383 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"2106_CR32","doi-asserted-by":"publisher","first-page":"13497","DOI":"10.1038\/s41598-024-64400-1","volume":"14","author":"M Bashi","year":"2024","unstructured":"Bashi, M., Madanchi, H. & Yousefi, B. Investigation of cytotoxic effect and action mechanism of a synthetic peptide derivative of rabbit Cathelicidin against MDA-MB-231 breast Cancer cell line. Sci. Rep. 14, 13497. https:\/\/doi.org\/10.1038\/s41598-024-64400-1 (2024).","journal-title":"Sci. Rep."},{"key":"2106_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2211068211426550","volume":"17","author":"R Riahi","year":"2012","unstructured":"Riahi, R., Yang, Y., Zhang, D. D. & Wong, P. K. Advances in Wound-Healing assays for probing collective cell migration. SLAS Technol. 17, 59\u201365. https:\/\/doi.org\/10.1177\/2211068211426550 (2012).","journal-title":"SLAS Technol."},{"key":"2106_CR34","doi-asserted-by":"publisher","first-page":"16177","DOI":"10.1038\/s41598-019-52652-1","volume":"9","author":"S Daunys","year":"2019","unstructured":"Daunys, S., Matulis, D. & Petrikait\u0117, V. Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic Cancer cell cultures. Sci. Rep. 9, 16177. https:\/\/doi.org\/10.1038\/s41598-019-52652-1 (2019).","journal-title":"Sci. Rep."},{"key":"2106_CR35","doi-asserted-by":"publisher","first-page":"13201","DOI":"10.2147\/OTT.S283033","volume":"13","author":"M Bytautaite","year":"2020","unstructured":"Bytautaite, M. & Petrikaite, V. Comparative study of lipophilic Statin activity in 2D and 3D in vitro models of human breast Cancer cell lines MDA-MB-231 and MCF-7. Onco Targets Ther. 13, 13201\u201313209. https:\/\/doi.org\/10.2147\/OTT.S283033 (2020).","journal-title":"Onco Targets Ther."},{"key":"2106_CR36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7150\/jca.2.458","volume":"2","author":"L Li","year":"2011","unstructured":"Li, L. & Lu, Y. Optimizing a 3D culture system to study the interaction between epithelial breast Cancer and its surrounding fibroblasts. J. Cancer. 2, 458\u2013466. https:\/\/doi.org\/10.7150\/jca.2.458 (2011).","journal-title":"J. Cancer"},{"key":"2106_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fonc.2017.00293","volume":"7","author":"F Mittler","year":"2017","unstructured":"Mittler, F. et al. High-Content monitoring of drug effects in a 3D spheroid model. Front. Oncol. 7, 293. https:\/\/doi.org\/10.3389\/fonc.2017.00293 (2017).","journal-title":"Front. Oncol."},{"key":"2106_CR38","doi-asserted-by":"publisher","unstructured":"Skarait\u0117, I., Maccioni, E. & Petrikait\u0117, V. Anticancer activity of Sunitinib analogues in human pancreatic Cancer cell cultures under normoxia and hypoxia. IJMS 24 (5422). https:\/\/doi.org\/10.3390\/ijms24065422 (2023).","DOI":"10.3390\/ijms24065422"},{"key":"2106_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/pharmaceutics16060735","volume":"16","author":"R \u0160edbar\u0117","year":"2024","unstructured":"\u0160edbar\u0117, R., Janulis, V., Pavilonis, A. & Petrikaite, V. Comparative in vitro study: assessing phytochemical, antioxidant, antimicrobial, and anticancer properties of Vaccinium Macrocarpon Aiton and Vaccinium Oxycoccos L. Fruit extracts. Pharmaceutics 16, 735. https:\/\/doi.org\/10.3390\/pharmaceutics16060735 (2024).","journal-title":"Pharmaceutics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02106-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T06:22:13Z","timestamp":1747808533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02106-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02106-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17590"}}